Health Emergency Preparedness, Response and Resilience Program Using the Multiphase Programmatic App ( - Тендер #71155603)

• Project ID

P180127

• Project Title

Health Emergency Preparedness, Response and Resilience Program Using the Multiphase Programmatic App

• Country

Eastern and Southern Africa

• Notice No

OP00430201

• Notice Type

Request for Expression of Interest

• Notice Status

Published

• Borrower Bid Reference

KE-KBI-537982-CS-QCBS

• Procurement Method

Quality And Cost-Based Selection

• Language of Notice

English

• Submission Deadline Date/Time

Mar 31, 2026 10:00

• Published Date

Mar 05, 2026

• CONTACT INFORMATION
• Organization/Department

The Kenya Biovax Institute Limited

• Name

Rabera Kenyanya

• Address

The Kenya Biovax Institute Limited P.O. Box 40779-00100 Nairobi Kenya Email: info@biovax.go.ke

• City

• Province/State

Eastern and Southern Africa

• Postal Code

• Country

Eastern and Southern Africa

• Phone

0700668146

• Email

Rabera.kenyanya@biovax.go.ke

• Website

biovax.go.ke

REQUEST FOR EXPRESSIONS OF INTEREST

(CONSULTING SERVICES – FIRMS SELECTION)

1. The Government of Kenya (GoK) has received financing from the World Bank toward the cost of the Health Emergency Preparedness Response and Resilience (HEPRR) Project and intends to apply part of the proceeds for consulting services.

2. The consulting services (“the Services”) includes consulting services for Preparation of Preliminary Engineering Designs, Employer Requirements and Construction Supervision, and Good Manufacturing Practice Compliance Certification for Establishment of a Human Vaccines and Biologicals Fill–Finish Manufacturing Facility. The duration of the assignment will be Thirty-Six (36) Months from the contract commencement date.

3. The detailed Terms of Reference (ToR) for the assignment can be found at the following Kenya Biovax Institute Limited’s website: www.biovax.go.ke.

4. The Kenya Biovax Institute Limited now invites eligible consulting firms (“Consultants”) to indicate their interest in providing the Services. Interested Consultants should provide information demonstrating that they have the required qualifications and relevant experience to perform the Services. The shortlisting criteria are:

4.1 Core business and years in business

The consulting firm shall be legally registered/incorporated as a consulting entity and shall have its core business providing expertise in project management, preparation of preliminary designs, employers requirements, construction supervision, GMP compliance certification support and technology transfer projects oversight for pharmaceutical/biopharmaceutical/human vaccines and biologicals manufacturing companies, for a minimum period of ten (10) years.

4.2 Relevant experience:

The consulting firm shall demonstrate having successfully executed, completed and supported GMP compliance certification of at least one (1) assignment of similar nature, scope, scale, and complexity within the last ten (10) years.

Details of similar assignments shall be provided in the expression of interest, including the Client’s name and address, scope of services, contract value, period of execution, and the consultant’s role.

4.3Technical and managerial capability of the firm:

The consulting firm shall demonstrate adequate technical capacity and managerial capability to undertake this assignment, supported by submitted company profiles, organizational structures, and availability of suitably qualified experts.

Key Experts will not be evaluated at the shortlisting stage.

5. The attention of interested Consultants is drawn to Section III, paragraphs, 3.14, 3.16, and 3.17 of the World Bank’s “Procurement Regulations for IPF Borrowers” First Published July 2016 and Revised Fourth Edition, November 2020 (“Procurement Regulations”), setting forth the World Bank’s policy on conflict of interest.

6. Consultants may associate with other firms to enhance their qualifications but should indicate clearly whether the association is in the form of a joint venture and/or a sub-consultancy. In the case of a joint venture, all the partners in the joint venture shall be jointly and severally liable for the entire contract, if selected.

7. A Consultant will be selected in accordance with the Quality Cost Based Selection (QCBS) method set out in the World Bank Procurement Regulations.

8. Further information can be obtained at the address below during office hours 0900 to 1700 hours East African Time (EAT) from Monday to Friday excluding lunch hour (1300 to 1400hours (EAT) and public holidays.

9. Expressions of Interest must be delivered in a written form to the address below In person or by mail or email and be clearly marked “Expression of Interest Preparation of Preliminary Engineering Designs, Employer Requirements and Construction Supervision, and Good Manufacturing Practice Compliance Certification for Establishment of a Human Vaccines and Biologicals Fill–Finish Manufacturing Facility” by 31st March 2026 at 1000 hours East African Time.

EOI submissions delivered by email should strictly be sent to: HEPRRProcurement@biovax.go.ke

Address:

Director General/CEO

Kenya BioVax Institute Limited

Kenya Women Finance Trust- Upper Hill

3rd Floor, Wing A

P.O. Box 40799 – 00100

Nairobi, Kenya

Tel: +254 775 751 639

E-mail: heprr@biovax.go.ke

Источник закупки